Stoichiometric Antibody−Polymer−Drug Conjugate for Effective Low-Dose Treatment of Breast Cancer.
L'équipe CBF vient de publier un article intitulé "Stoichiometric Antibody−Polymer−Drug Conjugate for Effective Low-Dose Treatment of Breast Cancer", dans Biomacromolecules.